Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities.
Eclipse Regenesis's investors include National Institutes of Health, Atacama Ventures, NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR), Consortium For Technology & Innovation in Pediatrics.
Eclipse Regenesis is headquartered in Menlo Park, United States.
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities.
Eclipse Regenesis is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eclipse Regenesis — Funding & Investors." VCBacked, August 15, 2022, https://www.vcbacked.co/company/eclipse-regenesis. Accessed July 20, 2026.
VCBacked. (2022). Eclipse Regenesis — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/eclipse-regenesis
{{cite web |title=Eclipse Regenesis — Funding & Investors |url=https://www.vcbacked.co/company/eclipse-regenesis |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated